Manulife (Manufacturers Life Insurance)’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $280K | Buy |
19,436
+885
| +5% | +$12.8K | ﹤0.01% | 2412 |
|
2025
Q1 | $128K | Buy |
18,551
+1,010
| +6% | +$6.97K | ﹤0.01% | 2636 |
|
2024
Q4 | $93.1K | Sell |
17,541
-2,191
| -11% | -$11.6K | ﹤0.01% | 2834 |
|
2024
Q3 | $72K | Buy |
19,732
+8,485
| +75% | +$31K | ﹤0.01% | 2939 |
|
2024
Q2 | $30.7K | Buy |
+11,247
| New | +$30.7K | ﹤0.01% | 2948 |
|
2022
Q2 | – | Sell |
-11,279
| Closed | -$27.7K | – | 3165 |
|
2022
Q1 | $27.7K | Sell |
11,279
-15,098
| -57% | -$37.1K | ﹤0.01% | 3052 |
|
2021
Q4 | $99 | Buy |
26,377
+143
| +0.5% | +$1 | ﹤0.01% | 3054 |
|
2021
Q3 | $164K | Sell |
26,234
-909
| -3% | -$5.68K | ﹤0.01% | 3044 |
|
2021
Q2 | $268K | Buy |
27,143
+3,579
| +15% | +$35.3K | ﹤0.01% | 2896 |
|
2021
Q1 | $220K | Sell |
23,564
-3,809
| -14% | -$35.6K | ﹤0.01% | 2834 |
|
2020
Q4 | $131K | Buy |
27,373
+1,388
| +5% | +$6.64K | ﹤0.01% | 2903 |
|
2020
Q3 | $104K | Hold |
25,985
| – | – | ﹤0.01% | 2791 |
|
2020
Q2 | $118K | Sell |
25,985
-2,017
| -7% | -$9.16K | ﹤0.01% | 2699 |
|
2020
Q1 | $91K | Buy |
28,002
+1,803
| +7% | +$5.86K | ﹤0.01% | 2602 |
|
2019
Q4 | $113K | Sell |
26,199
-799
| -3% | -$3.45K | ﹤0.01% | 2769 |
|
2019
Q3 | $110K | Hold |
26,998
| – | – | ﹤0.01% | 2807 |
|
2019
Q2 | $126K | Sell |
26,998
-1,962
| -7% | -$9.16K | ﹤0.01% | 2838 |
|
2019
Q1 | $121K | Buy |
+28,960
| New | +$121K | ﹤0.01% | 2552 |
|